MiNK Therapeutics, Inc.INKTNASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-2.50
↑ 73% vs avg
Percentile
P60
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-9.42
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2024 | -2.50 | -66.7% |
| 2023 | -1.50 | +38.7% |
| 2022 | -2.45 | +38.6% |
| 2021 | -3.99 | +87.5% |
| 2020 | -31.88 | -124.5% |
| 2019 | -14.21 | - |